References
- Shi S, Qin M, Shen B, et al. Association of Cardiac Injury With
Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA
2020 Mar 25th, online first publication. DOI:
10.1001/jamacardio.2020.0950.
- Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138
Hospitalized Patients With 2019 Novel Coronavirus-Infected
Pneumonia in Wuhan, China. JAMA 2020 Feb 7th, online
first. DOI: 10.1001/jama.2020.1585.
- Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis saved
with glucocorticoid and human immunoglobulin. Eur Heart J 2020 Mar
16th online first publication. DOI:
10.1093/eurheartj/ehaa190.
- Sellers SA, Hagan RS, Hayden FG, Fischer WA 2nd. The
hidden burden of influenza: A review of the extra-pulmonary
complications of influenza infection. Influenza Other Respir Viruses
2017;11:372-393.
- Alexander LK, Small JD, Edwards S, Baric RS. An experimental
model for dilated cardiomyopathy after rabbit coronavirus infection. J
Infect Dis 1992;166:978-85.
- Xiong TY, Redwood S, Prendergast B, Chen M. Coronaviruses and the
cardiovascular system: acute and long-term implications. Eur Heart J
2020 Mar 18th, online first publication. DOI:
10.1093/eurheartj/ehaa231.
- Yu CM, Wong RS, Wu EB, et al. Cardiovascular complications of severe
acute respiratory syndrome. Postgrad Med J 2006;82:140-4.
- Lau ST, Yu WC, Mok NS, Tsui PT, Tong WL, Cheng SW. Tachycardia amongst
subjects recovering from severe acute respiratory syndrome (SARS). Int
J Cardiol 2005;100:167-9.
- Pan SF, Zhang HY, Li CS, Wang C. Cardiac arrest in
severe acute respiratory syndrome: analysis of 15 cases. Zhonghua Jie
He He Hu Xi Za Zhi. 2003;26:602-5.
- Centers for Disease Control and Prevention (CDC). Update: Severe
respiratory illness associated with Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-worldwide, 2012-2013.
MMWR Morb Mortal Wkly Rep 2013;62:480-3.
- Maslow JN. Vaccines for emerging infectious diseases: Lessons from
MERS coronavirus and Zika virus. Hum Vaccin Immunother.
2017;13:2918-2930.
- Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East
respiratory syndrome coronavirus (MERS-CoV): a systematic
review and meta-analysis. Int J Infect Dis 2016;49:129-33.
- Saad M, Omrani AS, Baig K, et al. Clinical aspects and outcomes of 70
patients with Middle East respiratory syndrome coronavirus infection:
a single-center experience in Saudi Arabia. Int J Infect Dis
2014;29:301-6.
- Al-Abdallat MM, Payne DC, Alqasrawi S, et al.
Hospital-associated outbreak of Middle East respiratory syndrome
coronavirus: a serologic, epidemiologic, and clinical description.
Clin Infect Dis 2014;59:1225-33.
- Alhogbani T. Acute myocarditis associated with novel Middle east
respiratory syndrome coronavirus. Ann Saudi Med. 2016;36:78-80.
- Nguyen JL, Yang W, Ito K, Matte TD, Shaman J, Kinney PL. Seasonal
Influenza Infections and Cardiovascular Disease Mortality. AMA Cardiol
2016;1:274-81.
- Madjid M, Connolly AT, Nabutovsky Y, Safavi-Naeini P, Razavi M, Miller
CC. Effect of High Influenza Activity on Risk of
Ventricular Arrhythmias Requiring Therapy in Patients With
Implantable Cardiac Defibrillators and Cardiac Resynchronization
Therapy Defibrillators. Am J Cardiol 2019;124:44-50.
- Ang LW, Yap J, Lee V, et al. Influenza-Associated Hospitalizations for
Cardiovascular Diseases in the Tropics. Am J Epidemiol
2017;186:202-209.
- Modin D, Jørgensen ME, Gislason G, et al. Influenza Vaccine in Heart
Failure. Circulation. 2019;139:575-586.
- Huang C, Wang Y, Li X, et al. Clinical features of patients infected
with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506.
- Guo T, Fan Y, Chen M, et al. Cardiovascular Implications of Fatal
Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA
Cardiol 2020 Mar 27th, online first publication DOI:
10.1001/jamacardio.2020.1017.
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for
mortality of adult inpatients with COVID-19 in Wuhan, China: a
retrospective cohort study. Lancet 2020;395:1054-1062.
- Li SS, Cheng C, Fu C, et al. Left ventricular performance in patients
with severe acute respiratory syndrome: a 30-day echocardiographic
follow-up study. Circulation 2003;108:1798-803.
- Harris JE, Shah PJ, Korimilli V, Win H. Frequency of troponin
elevations in patients with influenza infection during the 2017–2018
influenza season. Int J Cardiol Heart Vasc 2019;22:145-147.
- Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities in
the novel Wuhan coronavirus (COVID-19) infection: a systematic review
and meta-analysis.
Int
J Infect Dis 2020 Mar 12th, online first
publication. DOI: 10.1016/j.ijid.2020.03.017.
- Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular
system. Nat Rev Cardiol. 2020 Mar 5th, online first
publication. DOI: 10.1038/s41569-020-0360-5.
- Oudit GY, Kassiri Z, Jiang C, et al. SARS-coronavirus modulation of
myocardial ACE2 expression and inflammation in patients with SAR. Eur
J Clin Invest 2009;39:618-25.
- Wong CK, Lam CW, Wu AK, et al . Plasma inflammatory cytokines and
chemokines in severe acute respiratory syndrome. Clin Exp Immunol
2004;136:95-103.
- Cameron MJ, Bermejo-Martin JF, Danesh A, Muller MP, Kelvin DJ. Human
immunopathogenesis of severe acute respiratory syndrome (SARS). Virus
Res. 2008;133:13-9.
- Yang C, Jin Z. An Acute Respiratory Infection Runs Into the Most
Common Noncommunicable Epidemic—COVID-19 and Cardiovascular
Diseases. JAMA Cardiol 2020 March 25th, online first
publication. DOI:10.1001/jamacardio.2020.0934.
- Ratliff NB, Estes ML, McMahon JT, Myles JL.
Chloroquine-induced cardiomyopathy. Arch Pathol Lab Med 1988;112:578.
- Seshadri MS, John L, Varkey K, Koshy TS. Ventricular tachycardia in
a patient on dehydroemetine and chloroquine for amoebic liver abscess.
Med J Aust 1979;1:406-7.
- Fauchier JP, Fauchier L, Babuty D, Breuillac JC, Cosnay P, Rouesnel P.
Drug-induced ventricular tachycardia. Arch Mal Coeur Vaiss
1993;86:757-67.
- Siqueira-Batista R, Ramos Júnior AN, Pessanha BS, Sforza-de-Almeida
MP, Potsch DF. Chloroquine and cardiac arrhythmia: case report. East
Afr Med J 1998;75:117-9.
- Harris L, Downar E, Shaikh NA, Chen T. Antiarrhythmic potential of
chloroquine: new use for an old drug. Can J Cardiolo 1988;4:295-300.
- Verny C, de Gennes C, Sebastien P, et al. Heart conduction disorders
in long-term treatment with chloroquine: two new cases. Presse Med
1992;2:800-4.
- Capel RA, Herring N, Kalla M, et al. Hydroxychloroquine reduces heart
rate by modulating the hyperpolarization-activated current If: Novel
electrophysiological insights and therapeutic potential. Heart Rhythm
2015;12:2186-94.
- O’Laughlin JP, Mehta PH, Wong BC. Life Threatening Severe QTc
Prolongation in Patient with Systemic Lupus Erythematosus due to
Hydroxychloroquine. Case Rep Cardiol 2016;2016:4626279.
- Lee N, Hui D, Wu A, et al. A major outbreak of severe acute
respiratory syndrome in Hong Kong. N Engl J Med 2003;348:1986-94.
- Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and
short-term outcomes of 144 patients with SARS in the greater Toronto
area. JAMA 2003;289:2801-9.
- Al-Tawfiq JA, Hinedi K, Ghandour J, et al. Middle East respiratory
syndrome coronavirus: a case-control study of hospitalized patients.
Clin Infect Dis 2014;59:160-5.
- Schoen K, Horvat N, Guerreiro NFC, de Castro I, de Giassi KS. Spectrum
of clinical and radiographic findings in patients with diagnosis of
H1N1 and correlation with clinical severity. BMC Infect Dis
2019;19:964.
- Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological,
demographic, and clinical characteristics of 47 cases of Middle East
respiratory syndrome coronavirus disease from Saudi Arabia: a
descriptive study. Lancet Infect Dis 2013;13:752-61.
- Inciardi RM, Lupi L, Zaccone G, et al. Cardiac Involvement in a
Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol 2020
Mar 27th, online first publication. DOI:
10.1001/jamacardio.2020.1096.
Table 1. Cohorts that evaluated cardiac manifestations in
SARS-CoV, MERS-CoV, H1N1, and SARS-CoV-2